PPBT
Purple Biotech
NASDAQ: PPBT · HEALTHCARE · BIOTECHNOLOGY
$4.23
-6.90% today
Updated 2026-04-29
Market cap
$6.95M
P/E ratio
—
P/S ratio
58.08x
EPS (TTM)
$-54.00
Dividend yield
—
52W range
$4 – $29
Volume
0.0M
Purple Biotech (PPBT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-124.50%
ROA
-16.00%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-2.63M | — | — | — |
| 2014 | — | $-5.25M | — | — | — |
| 2015 | — | $-4.20M | — | — | — |
| 2016 | — | $-12.13M | — | — | — |
| 2017 | $100000.00 | $-12.18M | 100.00% | -11,966.00% | -12,177.00% |
| 2018 | $1.00M | $-5.20M | 100.00% | -782.60% | -520.00% |
| 2019 | $1.00M | $-5.85M | 99.99% | -715.60% | -585.00% |
| 2020 | $1.00M | $-28.00M | 99.99% | -1,323.90% | -2,799.90% |
| 2021 | $-320000.00 | $-18.38M | 0.02% | 5,604.38% | 5,745.00% |
| 2022 | $-910000.00 | $-21.67M | 0.01% | 2,483.85% | 2,381.10% |
| 2023 | $195804.00 | $-19880.00 | -0.10% | -11,374.13% | -10.15% |
| 2024 | $0.00 | $-7.24M | — | — | — |
| 2025 | $0.00 | $-26.81M | — | — | — |